Latest filing published 24 Feb 2016 for Regulus Therapeutics Inc., €6.5M.
Insider track record
No signal scores available.
Alnylam Pharmaceuticals, Inc.: trading record in brief
Alnylam Pharmaceuticals, Inc. appears in our data through filings on Regulus Therapeutics Inc. shares, published by SEC (Form 4). Between 10 October 2012 and 23 February 2016, the trades on record add up to 67 filings.
On the market, this insider has only sold: 66 sales, €9.8M in total. Since January 2016: no purchases and 1 sale on the market.
Most recently, on 24 February 2016, the filings show an open-market sale worth €6.5M in Regulus Therapeutics Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alnylam Pharmaceuticals, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares@ US$7.18100.0% of flowCommon StockSEC:0001209191-16-102044:0
- 109,534 shares@ US$14.00Common StockSEC:0001209191-14-064841:0
- 1,700 shares@ US$14.24Common StockSEC:0001209191-14-064841:1
- 1,850 shares@ US$15.19Common StockSEC:0001209191-14-064841:2
- 4,300 shares@ US$6.67Common StockSEC:0001209191-14-063855:0
- 4,800 shares@ US$6.76Common StockSEC:0001209191-14-063855:1
- 3,000 shares@ US$6.79Common StockSEC:0001209191-14-063855:2
- 3,300 shares@ US$6.63Common StockSEC:0001209191-14-062936:0
- 4,750 shares@ US$6.58Common StockSEC:0001209191-14-062936:1
- 2,000 shares@ US$6.41Common StockSEC:0001209191-14-062936:2
- 3,250 shares@ US$6.71Common StockSEC:0001209191-14-061843:0
- 3,750 shares@ US$6.64Common StockSEC:0001209191-14-061843:1
- 3,300 shares@ US$6.88Common StockSEC:0001209191-14-061843:2
- 3,750 shares@ US$7.19Common StockSEC:0001209191-14-060003:0
- 2,500 shares@ US$7.12Common StockSEC:0001209191-14-060003:1
- 2,500 shares@ US$7.04Common StockSEC:0001209191-14-060003:2
- 2,100 shares@ US$7.43Common StockSEC:0001209191-14-058820:0
- 1,500 shares@ US$7.40Common StockSEC:0001209191-14-058820:1
- 4,100 shares@ US$7.22Common StockSEC:0001209191-14-058820:2
- 2,000 shares@ US$7.70Common StockSEC:0001209191-14-057757:0
- 3,400 shares@ US$7.83Common StockSEC:0001209191-14-057757:1
- 3,500 shares@ US$7.96Common StockSEC:0001209191-14-057757:2
- 1,650 shares@ US$6.95Common StockSEC:0001209191-14-056231:0
- 6,000 shares@ US$7.11Common StockSEC:0001209191-14-056231:1
- 2,400 shares@ US$7.07Common StockSEC:0001209191-14-056231:2
25 of 55 declarations
